Peptic Ulcer Global Market Report 2024

Description

An open sore or raw area in the stomach lining or intestine is known as a peptic ulcer. It is primarily a result of the erosion of the protective lining of the stomach or the upper part of the small intestine, known as the duodenum. Common symptoms of peptic ulcers include upper abdominal pain or discomfort and symptoms of acid reflux, such as heartburn, sometimes accompanied by nausea.

The primary disease indications consist of gastritis, gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease (GERD). Gastritis is a medical condition characterized by inflammation, irritation, or erosion of the stomach lining. The typical approach to treating gastritis involves medications such as proton pump inhibitors and lifestyle adjustments. The drugs utilized include proton pump inhibitors (PPI), H2 antagonists, antibiotics, and other pharmaceuticals, which are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

The peptic ulcer market research report is one of a series of new reports from The Business Research Company that provides peptic ulcer market statistics, including peptic ulcer industry global market size, regional shares, competitors with a peptic ulcer market share, detailed peptic ulcer market segments, market trends and opportunities, and any further data you may need to thrive in the peptic ulcer industry. This peptic ulcer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptic ulcer market size has grown steadily in recent years. It will grow from $3.94 billion in 2023 to $4.1 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth observed in the historical period can be ascribed to several factors, including an increased prevalence of Helicobacter pylori infection, a rise in the use of nonsteroidal anti-inflammatory drugs (NSAIDs), shifts in lifestyles and dietary habits, awareness campaigns and educational initiatives, and a heightened focus on stress management.

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.69 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%. The anticipated growth in the forecast period can be ascribed to emerging therapies and treatment modalities, a growing geriatric population, the integration of precision medicine, preventive measures, and health promotion, as well as ongoing research and clinical trials. Notable trends expected in the forecast period encompass digital health solutions, advancements in treatment modalities, a rising prevalence of Helicobacter pylori infection, the integration of diagnostic imaging technologies, and an increased utilization of combination therapies.

The anticipated rise in obesity prevalence is poised to drive the peptic ulcer market's growth. Obesity, characterized by excess body fat accumulation, typically results in a body mass index (BMI) of 30 or higher and can stem from genetic, environmental, and lifestyle factors such as poor diet and physical inactivity. This condition leads to increased stomach acid production, weakening the protective mucosal lining and contributing to peptic ulcer development. Moreover, excess weight promotes gut inflammation, further increasing the risk of peptic ulcers. Notably, the World Obesity Atlas 2022 report indicated that the global obesity estimate in 2020 was 764 million, projected to reach 892 million by 2025, underscoring the driving force of obesity on the peptic ulcer market.

The escalating rates of smoking are expected to fuel the peptic ulcer market's growth in the foreseeable future. Smoking, the inhalation of vapors from burning plant-based products such as tobacco or marijuana, is a well-established contributor to peptic ulcer disease. Smoking harms the stomach and duodenal linings, reduces blood supply to the stomach, and increases stomach acid production, elevating the incidence of peptic ulcers. For example, data from Quit Victoria in June 2023 highlighted a threefold increase in current cigarette smoking among 14-17-year-olds over four years, reaching 6.7% in 2022. Consequently, the rising smoking rates serve as a driving factor for the peptic ulcer market.

The substantial treatment costs represent a major impediment to the peptic ulcer market's growth during the forecast period. High treatment expenses for peptic ulcers pose a significant burden on patients, healthcare systems, and employers due to the costly medications administered in hospitals for complicated cases. As an illustration, information from the National Library of Medicine in February 2023 revealed that the annual cost of peptic ulcer disease in the USA is 5.65 billion USD, encompassing all medical expenditures. Consequently, the elevated treatment costs for peptic ulcers hinder the market's growth.

Companies engaged in the peptic ulcer market are actively developing innovative products and solutions, securing approval from regulatory agencies to gain a competitive edge. Drug development plays a pivotal role in managing and treating peptic ulcers, addressing symptom management, promoting healing, preventing complications, and treating underlying issues. Notably, in December 2021, the U.S. Food and Drug Administration granted approval to Dartisla ODT as the first medication specifically authorized for supplementing peptic ulcer disease treatment. Dartisla ODT, known for its anticholinergic properties, contains 1.7 mg of glycopyrrolate in each tablet.

In July 2022, Juvise Pharmaceuticals, a France-based pharmaceutical company, acquired the global commercial rights to Pylera from AbbVie Inc. for $408 million (€400 million). Pylera, an antimicrobial tri-therapy, targets peptic ulcers caused by Helicobacter pylori (H. pylori) infection. This acquisition is expected to facilitate Juvise Pharmaceuticals' expansion of its gastro-intestinal medicine product portfolio, serving as a strategic addition for geographic expansion. AbbVie Inc., a U.S.-based pharmaceutical company, specializes in providing various medications for diverse conditions, including peptic ulcers.

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

North America was the largest region in the peptic ulcer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptic ulcer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peptic ulcer market consists of revenues earned by entities by providing treatment services related to peptic ulcer such as surgeries, endoscopy, blood tests, and physical exams. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptic ulcer market also includes sales of acid blockers, cytoprotective agents, bismuth subsalicylate, and mastic powder. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptic Ulcer Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptic ulcer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peptic ulcer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptic ulcer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs
3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-commerce
Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13434

1. Executive Summary

2. Peptic Ulcer Market Characteristics

3. Peptic Ulcer Market Trends And Strategies

4. Peptic Ulcer Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Peptic Ulcer Market Size and Growth

5.1. Global Peptic Ulcer Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Peptic Ulcer Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Peptic Ulcer Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Peptic Ulcer Market Segmentation

6.1. Global Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
6.2. Global Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Proton Pump Inhibitors (PPI)
H2 Antagonists
Antibiotics
Other Drug Types
6.3. Global Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Private Clinics
Drug Store
Retail Pharmacies
E-commerce

7. Peptic Ulcer Market Regional And Country Analysis

7.1. Global Peptic Ulcer Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Peptic Ulcer Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Peptic Ulcer Market

8.1. Asia-Pacific Peptic Ulcer Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Peptic Ulcer Market

9.1. China Peptic Ulcer Market Overview
9.2. China Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Peptic Ulcer Market

10.1. India Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Peptic Ulcer Market

11.1. Japan Peptic Ulcer Market Overview
11.2. Japan Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Peptic Ulcer Market

12.1. Australia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Peptic Ulcer Market

13.1. Indonesia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Peptic Ulcer Market

14.1. South Korea Peptic Ulcer Market Overview
14.2. South Korea Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Peptic Ulcer Market

15.1. Western Europe Peptic Ulcer Market Overview
15.2. Western Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Peptic Ulcer Market

16.1. UK Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Peptic Ulcer Market

17.1. Germany Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Peptic Ulcer Market

18.5. France Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Peptic Ulcer Market

19.9. Italy Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Peptic Ulcer Market

20.13. Spain Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Peptic Ulcer Market

21.1. Eastern Europe Peptic Ulcer Market Overview
21.2. Eastern Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Peptic Ulcer Market

22.1. Russia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Peptic Ulcer Market

23.1. North America Peptic Ulcer Market Overview
23.2. North America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Peptic Ulcer Market

24.1. USA Peptic Ulcer Market Overview
24.2. USA Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Peptic Ulcer Market

25.1. Canada Peptic Ulcer Market Overview
25.2. Canada Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Peptic Ulcer Market

26.1. South America Peptic Ulcer Market Overview
26.2. South America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Peptic Ulcer Market

27.1. Brazil Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Peptic Ulcer Market

28.1. Middle East Peptic Ulcer Market Overview
28.2. Middle East Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Peptic Ulcer Market

29.1. Africa Peptic Ulcer Market Overview
29.2. Africa Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Peptic Ulcer Market Competitive Landscape And Company Profiles

30.1. Peptic Ulcer Market Competitive Landscape
30.2. Peptic Ulcer Market Company Profiles
- 30.2.1. Johnson & Johnson
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bayer AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Novartis AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Peptic Ulcer Market Other Major And Innovative Companies

31.1. Sanofi S.A
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca plc
31.4. Abbott Laboratories
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Amgen Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. CSL Limited
31.11. Boehringer Ingelheim International GmbH
31.12. Eisai Co. Ltd.
31.13. Sun Pharmaceutical Industries Ltd.
31.14. Otsuka Pharmaceutical Company
31.15. Dr. Reddy's Laboratories Ltd.

32. Global Peptic Ulcer Market Competitive Benchmarking

33. Global Peptic Ulcer Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Peptic Ulcer Market

35. Peptic Ulcer Market Future Outlook and Potential Analysis

35.1 Peptic Ulcer Market In 2028 - Countries Offering Most New Opportunities
35.2 Peptic Ulcer Market In 2028 - Segments Offering Most New Opportunities
35.3 Peptic Ulcer Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer